Sorrento's Covid-19 Antibody in Question

The video discusses the role of antibodies in COVID-19 detection, vaccination, and treatment. It clarifies the use of the term 'cure' in the context of antibody research and outlines the timeline for human trials. The speaker also addresses acquisition offers for Sorento Therapeutics, emphasizing the company's value and ongoing research efforts.

What are the potential outcomes of having a neutralizing antibody in cell culture settings?

What challenges are faced in moving from animal studies to human trials for COVID-19 treatments?

What is the significance of having a fully human antibody library in the context of COVID-19 research?